CliffBio
small molecule

GILENYA

FINGOLIMOD HYDROCHLORIDE

Loss of exclusivityDecember 2027latest FDA-listed patent expiry
CompanyNovartis →View the full company profile on CliffBio

Drug detail

Brand nameGILENYA
Active ingredientFINGOLIMOD HYDROCHLORIDE
StrengthEQ 0.5MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2010
Marketing statusRX

Listed patents

PatentExpiresType
10543179December 2027use U-2719

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

GILENYA patent cliff — loss of exclusivity December 2027 | CliffBio